Skip to Content

Neostigmine

In some countries, this medicine may only be approved for veterinary use.

In the US, Neostigmine (neostigmine systemic) is a member of the following drug classes: cholinergic muscle stimulants, miscellaneous genitourinary tract agents and is used to treat Myasthenia Gravis, Reversal of Neuromuscular Blockade, Reversal of Nondepolarizing Muscle Relaxants and Urinary Retention.

US matches:

UK matches:

Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

N07AA01,S01EB06

CAS registry number (Chemical Abstracts Service)

0000059-99-4

Chemical Formula

C12-H20-N2-O3

Molecular Weight

240

Therapeutic Categories

Cholinesterase inhibitor (parasympathomimetic agent, indirect acting)

Treatment of myasthenia gravis

Chemical Name

Benzenaminium, 3-[[(dimetylamino)carbonyl]oxy]-N,N,N-trimetyl-,

Foreign Names

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide